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Abstract 
Background: Ruthin's coronavirus disease 2019 (COVID-19) diagnosis is based on the positive result of real-
time polymerase chain reaction (PCR) from the nasal and oropharyngeal swab. However, chest CT scans can 
play an important role in diagnosing patients with COVID-19. 
Cases Report: In this study, we reported a 44 years old female with a mild form of the COVID-19 who showed 
a positive result for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA for 44 days after 
symptom onset. The suspected case was detected using real-time PCR. After two weeks of hospitalization, the 
patient was discharged, but her molecular tests were performed twice after one month and 44 days, and they 
remained positive for SARS-CoV-2 RNA. 
Conclusion: In theory, if the patient becomes re-infected or the virus reacts, these individuals may serve as a 
transmission source. So far, the only way to screen for possible reinfection has been by using PCR on separate 
specimens. 
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Coronavirus virus disease 2019 (COVID-19) is a 
global concern caused by acute respiratory 
coronavirus syndrome 2 (SARS-CoV-2)1. 
Coronaviruses are enveloped viruses with a large plus-
strand RNA genome (⁓27–32 kb in size) that belongs 
to a genus of the Coronaviridae family2. These 
families mainly infect animals, including mammals 
and birds, and also they generally cause mild 
respiratory infections in humans. Three human 
coronavirus infections have resulted in lethal 
endemics, which include the severe acute respiratory 
syndrome (SARS) in 2003 from Southern China with a 
total of 8098 cases, Middle East respiratory syndrome 
(MERS) in 2012 from Saudi Arabia with a total of 
2,494 cases globally and SARS-CoV-2 (the cause of 
COVID-19 disease)] in 2019 from China with rapid 
spread around the world3-5. Understanding the 
mechanism of infectious virus shedding is crucial to 
guide infection prevention and control strategies6. 
Common symptoms of COVID-19 include fever and 
cough that usually resolve within four to eight days7. 
There are different assays to detect antibodies within 14 
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to 20 days of illness onset. However, the more 
sensitive method is the reverse transcriptase-
polymerase chain reaction (RT-PCR) assay. Detection 
of viral RNA by this method is the gold standard for 
COVID-19 diagnosis8. However, the critical issue 
with this test is the risk of eliciting false-negative and 
false-positive results. The sensitivity and specificity of 
the Real-Time RT-PCR test is not 100%; therefore, 
the laboratory standard techniques are important to 
explain the exact accurate results9-12.  
Some studies indicate that SARS-CoV-2 RNA can be 
identified in infected individuals 1-3 days before the 
symptom onset13, 14. The viral load reaches a peak in 
the first week of symptoms and gradually decreases 
over time14. Long-term shedding of viral RNA 
reported in patients with COVID-19, even after 
complete recovery, puts severe constraints on timely 
discharging recovered patients from the hospital and 
de-escalation of infection prevention and control 
practices15. In this regard, in the following study, we 
reported a patient with COVID-19 with prolonging 
positive result test of Real-Time PCR for SARS-CoV-
2 RNA even after being discharged from the hospital. 
Case Report 
A 44 years-old-woman was referred to Corona ward 
in Hamedan's Atieh Hospital with complaints of fever, 
shivering, dry cough, dyspnea, and respiratory 
dystrophy in 2020, October 1.  
Her vital signs were measured with noninvasive 
monitoring (BP: 110/70 mmHg, PR: 120 min, 
RR:26min, T:38, Spo2: 92% in room air), ABG at the 
same time (pH 7.3, pCO2:48.5, PO2:68.3, 
HCO3:26.2, BE:3.7, O2Sat:94.2%). Routine 
laboratory examinations were done according to Table 
1.  
The suspected case was tested using Real-Time PCR 
commercial kits (Pishtaz Teb Diagnostics - COVID-
19 One-Step COVID-19 RT-PCR Kit, Iran) according 
to the following procedures: 50°C 30 minutes; 95°C 
10 minutes; 94°C 15 seconds → 50°C 30 seconds → 
72°C 30 seconds, five cycles; and 94°C 10 seconds → 
58°C 30 seconds, 35 cycles. With a positive molecular 
result for diagnosis of COVID-19, the intensivist 
started treatment with oral Oseltamivir, Ceftriaxone, 
Azithromycin, and supplemental O2 therapy with a 
face mask. 
After two weeks of hospitalization, the patient was 
discharged, but her Real-Time PCR results were 
performed twice after one month and 44 days, and they 
remained positive for SARS-CoV-2 RNA. 
Discussion 
The current diagnosis of SARS-CoV-2 is based on the 
detection of viral nucleic acids. In this study, a case was 
reported that showed a positive result after being 
discharged from a hospital in Hamadan, Iran.  
The incubation period for COVID-19 is usually at 
intervals 14 days following exposure, with most cases 
occurring more or less four to five days once exposure. 
The duration and effectiveness of protection against 
COVID-19 are unknown; therefore, antibody tests (IgM 
and IgG) on blood are used to confirm past infection 
and presumed immunity to repeat infection. It was 
found that the immune response plays a vital role in the 
spectrum of disease caused by SARS-CoV-2. The 
immune system plays an important role in protecting 
against viruses and diseases by producing antibodies to 
limit pathogens16, 17. In patients with COVID-19, overly 
active immune systems can activate pathogenic T cells 
and inflammatory monocytes/macrophages to develop 
an inflammatory cytokine storm, resulting in severe 
damage to the lungs18, 19. By contrast, after being 
affected by the virus, immune responses produce 
specific antibodies to prevent viral disease by entirely 
blocking the virus from entering into host cells to 
prevent the infection. As a result, cytotoxic T cells play 
a crucial role in clearing and cleaning viral-infected 
cells 20. Continuous or repeated positive SARS-CoV-2 
PCR tests have been reported in samples taken from 
patients, weeks or months after recovery from an initial 
infection21. Some studies have shown that reinfection 
may occur up to 142 days after an individual has been 
discharged from the hospital. It is also thought that a 
potential reason for SARS-CoV-2 reactivation is a 
reduced humoral immune response22, 23.  
A 26-year-old patient from Rio de Janeiro, Brazil, 
showed signs of COVID-19 reinfection in another 
research. Clinical signs began consistently with 
infection with COVID-19 longer than 40 days after the 
initial mild infection. During the first hospitalization, 
the viral load of the second infection was more 
significant than in the first. Finally, only after the 
second episode of infection was a detectable antibody 
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for SARS-CoV-224.  
Prolonged detection of SARS-CoV-2 RNA and 
recurrence of PCR-positive tests are widely reported 
in patients even after full recovery from COVID-19; 
many of these patients do not seem to shed infectious 
viruses. Positive results that occurred might not be 
caused by virus recurrence or second virus infection. 
Researchers have suggested in one hypothesis that it 
is possible the virus genome is integrated into the 
human cell genome and has not been practically 
eliminated from the body25. Because the studies have 
shown that the only subgenomic sequences are 
detected that derived principally from the 3′ end of the 
viral genome integrated into the DNA of the host cell, 
the infectious virus cannot be produced from the 
integrated subgenomic SARS-CoV-2 sequences. 
In theory, if the patient becomes re-infected or the 
virus reactivates, these individuals may serve as a 
transmission source. So far, the only way to screen for 
possible reinfection has been by using PCR on 
separate specimens. This molecular assay cannot tell 
whether or not viruses are alive. There have been no 
documented instances of infection among individuals 
who had contact with re-positive patients26. 
Conclusion 
Based on this report, after 44 days, there were no 
significant differences in the Real-Time PCR results 
after drug treatment. This commentary raises a 
question: how should patients with COVID-19 be 
managed with a positive retest for SARS-CoV-2 
RNA? 
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